MERCK & CO Inc said on Monday it has applied for U.S. emergency use authorization for its drug to treat mild-to-moderate patients of COVID-19, putting it on course to become the first oral antiviral medication for the disease.
An authorization from the U.S. Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken at home.
The treatment, molnupiravir, cut the rate of hospitalization and death by 50% in a trial of mild-to-moderately ill patients who had at least one risk factor for the disease, according to data released earlier this month.
The interim efficacy data on the drug, developed with Ridgeback Biotherapeutics, had heavily dented the shares of COVID-19 vaccine makers and set off a scramble among nations, including Malaysia, South Korea and Singapore, to sign a supply deal with Merck.
The drugmaker has a U.S. government contract to supply 1.7 million courses at a price of $700 per course. Merck expects to produce 10 million courses of the treatment by the end of 2021.
It has also agreed to license the drug to several India-based generic drugmakers, which are expected to supply the treatment to more than 100 low- and middle-income countries.
Gilead Sciences Inc's infused antiviral remdesivir is generally given only once a patient is hospitalized.
Monoclonal antibody drugs from Regeneron Pharmaceuticals Inc and Eli Lilly, which are typically infused as well, have so far seen only limited use due to the difficulty in administering them.
Merck's shares opened roughly 1% higher before paring some gains to trade at $81.32.
Reuters
Tue Oct 12 2021
The interim efficacy data on the drug had heavily dented the shares of COVID-19 vaccine makers and set off a scramble among nations, including Malaysia, South Korea and Singapore, to sign a supply deal with Merck. - REUTERS
PRK Kuala Kubu Baharu: Proses penamaan calon lancar - Polis Selangor
Proses penamaan calon bagi PRK Kuala Kubu Baharu hari ini berjalan lancar tanpa sebarang insiden tidak diingini.
PRK Kuala Kubu Baharu: Pembangunan anak muda, wanita menjadi fokus Pang
Agenda pembangunan anak muda dan wanita akan menjadi fokus utama calon PH Pang Sock Tao, pada PRK Kuala Kubu Baharu.
Nahas helikopter Lumut: Kerajaan tidak bercadang gantung sementara helikoper Fennec, HOM
Kerajaan setakat ini tidak bercadang untuk menggantung sementara perkhidmatan helikopter jenis Fennec dan HOM.
Kejohanan Dunia Boling Padang: Tiga gangsa dalam tangan, misi tukar warna pingat
Skuad boling padang negara layak ke pusingan separuh akhir dalam kesemua kategori yang dipertandingkan di Kejohanan Dunia Dalam Dewan 2024.
Amerika Syarikat mungkin haramkan firma dron China, DJI
Amerika Syarikat kini turut sedang pertimbangkan DJI sebagai ancaman sekuriti, dan mungkin melakukan perundangan untuk mengharamkan DJI.
Bersatu ambil tindakan susulan terhadap enam ahli Parlimen - Muhyiddin
Bersatu sedang melaksanakan tindakan susulan terhadap enam ahli Parlimennya yang menyokong Perdana Menteri selepas meminda Perlembagaan parti bulan lalu.
'Made in Malaysia' - Apple punyai 19 kilang pembekal di negara ini
Malaysia merupakan salah satu negara yang mempunyai beberapa kilang pembekal yang menawarkan komponen kepada Apple.
SPRM lancar bilik gerakan PRK Kuala Kubu Baharu
SPRM melancarkan bilik gerakan, bagi membolehkan orang ramai menyalurkan maklumat serta aduan berkaitan perbuatan rasuah dan salah guna kuasa.
WEF anjur mesyuarat khas di Arab Saudi ketika suhu geopolitik Asia Barat memanas
WEF keluar dari kelazimannya dengan menganjurkan mesyuarat khas dua hari, 28-29 April 2024 di Riyadh, Arab Saudi.
Kerajaan rangka hala tuju beri lebih banyak perlindungan kepada kanak-kanak
Kerajaan akan merangka hala tuju bagi memberikan lebih banyak perlindungan dari segi undang-undang kepada kanak-kanak di negara ini.
WHO berjaya perlahankan penularan wabak Ebola di Congo
Pertubuhan Kesihatan Sedunia (WHO) berjaya memperlahankan penularan wabak Ebola yang mula menular di Republik Demokratik Congo (DRC) awal bulan lalu.